Wolverine Trading’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 1204 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 1290 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 1484 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 1294 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 1215 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 1167 |
|
2023
Q4 | – | Sell |
-15,149
| Closed | -$316K | – | 1244 |
|
2023
Q3 | $316K | Buy |
+15,149
| New | +$316K | ﹤0.01% | 743 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 1030 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 979 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 1201 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 1634 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 1895 |
|
2021
Q2 | – | Sell |
-26,042
| Closed | -$670K | – | 1750 |
|
2021
Q1 | $670K | Buy |
+26,042
| New | +$670K | ﹤0.01% | 805 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 1434 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 1207 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 1247 |
|
2020
Q1 | – | Sell |
-12,265
| Closed | -$529K | – | 1264 |
|
2019
Q4 | $529K | Buy |
+12,265
| New | +$529K | ﹤0.01% | 857 |
|
2019
Q2 | – | Sell |
-10,848
| Closed | -$291K | – | 1189 |
|
2019
Q1 | $291K | Sell |
10,848
-5,343
| -33% | -$143K | ﹤0.01% | 801 |
|
2018
Q4 | $253K | Buy |
+16,191
| New | +$253K | ﹤0.01% | 928 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 1461 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 1500 |
|
2017
Q3 | – | Sell |
-12,711
| Closed | -$365K | – | 1237 |
|
2017
Q2 | $365K | Sell |
12,711
-29,343
| -70% | -$843K | ﹤0.01% | 707 |
|
2017
Q1 | $1.43M | Buy |
42,054
+548
| +1% | +$18.7K | 0.01% | 254 |
|
2016
Q4 | $1.2M | Sell |
41,506
-1,079
| -3% | -$31.1K | 0.01% | 287 |
|
2016
Q3 | $1.39M | Buy |
+42,585
| New | +$1.39M | 0.01% | 239 |
|